Study of apoptosis in human lymphocytes by toxic substances implicated in Toxic Oil Syndrome

Toxicology

Volumn 118, Issue 1, 1997, Pages 71-82

  Gallardo, Soledad ^a   Cárdaba, Blanca ^a   Del Pozo, Victoria ^a   De Andrés, Belén ^a   Cortegano, Isabel ^a   Jurado, Aurora ^a   Tramón, Paloma ^a   Palomino, Pilar ^a   Lahoz, Carlos ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Apoptosis; Autoimmunity; Eosinophilia Myalgia Syndrome; Food poisoning; Toxic Oil Syndrome

Indexed keywords

ALANINE DERIVATIVE; ANILINE DERIVATIVE; DNA FRAGMENT; RAPESEED OIL;

APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; EOSINOPHILIA MYALGIA SYNDROME; HUMAN; HUMAN CELL; NORMAL HUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; TOXIC OIL SYNDROME;

ALANINE; ANILINE COMPOUNDS; APOPTOSIS; BRASSICA; CELLS, CULTURED; COLORING AGENTS; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; FOOD POISONING; HUMANS; LYMPHOCYTES; MICROSCOPY, FLUORESCENCE; PLANT OILS; PROPYLENE GLYCOLS; SYNDROME; TRIOLEIN; TRYPAN BLUE;

SINAPIS ARVENSIS; TOSCANA VIRUS;

EID: 0031567165     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(96)03585-8     Document Type: Article

References (46)

1. Adachi, J., Mio, T., Ueno, Y., Naito, T., Nishimura, A., Fujiwara, S., Sumino, K. and Tatsuno, Y. (1994) Identification of four metabolites of 3-(phenylamino)alanine, a constituent in L-tryptophan products implicated in eosinophilia-myalgia syndrome, in rats. Arch. Toxicol. 68(8), 500-505.
2. Adachi, J., Gomez, M., Smith, C.C. and Sternberg, E.M. (1995) Accumulation of 3-(phenylamino)alanine, a constituent in L-tryptophan products implicated in eosinophilia-myalgia syndrome, in blood and organs of the Lewis rats. Arch. Toxicol. 69(4), 266-270.
3. Aldridge, W.N. and Connors, T.A. (1982) Toxic oil syndrome in Spain. Food Chem. Toxicol. 20, 989-992.
4. Aldridge, W.N. (1992) The Toxic Oil Syndrome (TOS, 1981): from the disease towards a toxicological understanding of its chemical aetiology and mechanism. Toxicol. Lett. 64/65, 59-70.
5. Benson, L.M., Mayeno, A.M., Gleich, G.J. and Naylor, S. (1995) LC-APCI-MS/MS for the analysis of PAP biotransformation products. In: The 43rd ASMS Conference on Mass Spectrometry and Allied Topics, Atlanta, GA.
6. Biasi, D., Carletto, A., Caramaschi, P., Pacor, M.L., Spinaci, E. and Bambara, L.M. (1995) Scleroderma induced by chemical agents. Description of a case and review of the literature. Recent Prog. Med. 86, 155-158.
7. Buja, L.M., Eigenbrodt, M.L. and Eigenbrodt, E.H. (1993) Apoptosis and necrosis. Arch. Pathol. Lab. Med. 117, 1208-1214.
8. Buttke, T.M. and Sandstrom, S. (1994) Oxidative stress as a mediator of apoptosis. Immunol. Today 15(1), 7-10.
9. Casciola-Rosen, L.A., Anhalt, G. and Rosen, A. (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface blebs on apoptotic keratinocytes. J. Exp. Med. 179, 1317-1330.
10. Claw, D.J. and Crofford, L.J. (1995) Eosinophilic rheumatic disorders. Rheum. Dis. North Am. 21, 231-246.
11. Del Pozo, V., de Andrés, B., Gallardo, S., Cárdaba, B., de Arruda-chaves, E., Cortegano, I., Jurado, A., Palomino, P., Oliva, H., Aguilera, B., Posada, M. and Lahoz, C. (1997) Cytokine mRNA expression in lung tissue from toxic oil syndrome patients: a Th2 immunological mechanism. Toxicology, in press.
12. Dive, C., Gregory, C.D., Phipps, D.J., Evans, D.L., Milner, A.E. and Wyllie, A.H. (1992) Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim. Biophys. Acta 1133, 275-285.
13. Ferguson, M.A.J. and Williams, A.F. (1988) Cell-surface anchoring of proteins via glycosyl-phosphatidylinositol structures. Annu. Rev. Biochem. 57, 285-320.
14. Freixa, R., Casas, J., Messeguer, A. et al. (1986) Byproduct identification in the carbodiimide-assisted synthesis of fatty acid anilides related to Spanish toxic oil syndrome. J. Agric. Food Chem. 34, 738-742.
15. Gallardo, S., del Pozo, V., Cárdaba, B., de Andrés, B., Martin-Orozco, E., Fernandez, J.C., Tramón, P., Posada, M., Abaitua, I., Palomino, P. and Lahoz, C. (1994) Immunological basis of toxic oil syndrome. Toxicology 93, 289-299.
16. Gleichmann, H. and Gleichman, E. (1984) GVHD, a model for the Spanish Toxic Oil Syndrome. Lancet i, 1174-1175.
17. Grandjean, P. and Tarkowsky, S. (Eds.) (1984) Toxic Oil Syndrome. Mass food poisoning in Spain. WHO Regional Office for Europe, Copenhagen. Report of a WHO meeting: Madrid, 21-23 March, 1983, pp. 1-92.
18. Heiskanen, K.M., Naarala, J. and Savolainen, K.M. (1995) The effects of N-(5-vinyl-1,3-thiazolidin-2-ylidene (5-VTPA) on the changes in free intracellular calcium and the production of reactive oxygen metabolites in human leukocytes. Toxicology 100, 195-202.
19. Hill, R.H. Jr., Schurz, H.H., Posada, M., Abaitua, I., Philen, R.M., Kilbourne, E.M., Head, S.L., Bailey, S.M., Driskell, W.J., Barr, J.R. and Needham, L.L. (1995) Possible etiologic agents for Toxic Oil Syndrome: fatty acid esters of 3-(N-phenylamino)-1,2-propanediol. Arch. Environ. Contam. Toxicol. 28, 259-264.
20. Jiang, X., Khursigara, G. and Rubin, R.L. (1994) Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science 266, 810-813.
21. Kammuller, M.E., Pennincks, A.H. and Seinen, W. (1984) Spanish Toxic Oil Syndrome is a chemically induced graft-versus-host-like epidemic. Lancet 2, 805-806.
22. Kilbourne, E.M., Rigau-Pérez, J.G., Heath, C.W. Jr., Zack, M.M., Falk, H., Martin Marcos M. and de Carlos, A. (1983) Clinical epidemiology of toxic oil syndrome. New Engl. J. Med. 309, 1408-1414.
23. Kilbourne, E.M., Bernet, J.T. Jr., Posada de la Paz, M., Hill, R.H. Jr, Abaitua Borda, I., Kilbourne, B.W., Zack, M.N., Pérez, J.A.C., Díaz de Rojas, F., Pinilla, R.F., Montes, P.G., De la Fuente, G., Nadal, J., Benito, L.S., Tabuenca Oliver, J.M., Falk, H., Hannon, W.H., Needham, L.L. and Sampson, E. (1988) Chemical correlates of pathogenicity of oils related to the toxic oil syndrome in Spain. Am. J. Epidemiol. 127, 1210-1227.
24. Lahoz, C., Tricas, L., Vela, C., Lauzurica, P., Gurbindo, C. and Garcia, R. (1983) Hyper IgE, eosinophilia and immunological hyperreactivity due to ingestion of adultered rapeseed oil (Toxic Oil Syndrome). Eur. J. Respir. Dis. 62, 415-418.
25. Low, M.G. and Saltien, A.R. (1988) Structural and functional roles of glycisyl-phosphatidylinositol in membranes. Science 239, 268-275.
26. Maestro Duran, R., Ruiz Gutierrez, V. and Vazquez Roncero, A. (1986) Toxic oil syndrome in Spain: Toxicological study in mice of new aniline derivatives present in toxic oils. Grasas y Aceites 37, 207-204.
27. Mayeno, A.N., Belongia, E.A., Gleich, G.J. and Lundy, S.K. (1992) 3-(Phenylamino) alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome?. Mayo Clin. Proc. 67, 1134-1139.
28. Miller, S.A., Dykes, D. and Polesky, H.F. (1989) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16, 1216-1219.
29. Mower, D.A., Peckhan, D.V., Illera, V.A., Fishbaugh, J.K., Stunz, L.L. and Ashman, R.F. (1994) Decreased membrane phospholipid packing and decreased cell size precede DNA cleavage in mature mouse B cell apoptosis. J. Immunol. 152, 4832-4842.
30. Nicoletti, I., Migliorati, G., Pagliacci, M.C., Grignani, F. and Ricardi, C. (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139, 271-279.
31. Pestaña, A. and Muñoz, E. (1982) Anilides and the Spanish toxic oil syndrome. Nature 298, 608-612.
32. Philen, R.M. and Hill, R.H. Jr. (1993) 3-(Phenylamino)alanine - a link between eosiniphilia-myalgia syndrome and toxic oil syndrome? Mayo Clin. Proc. 68(2), 197-200.
33. Posada, M., Castro, M., Kilbourne, E.M., Diaz de Rojas, F., Abaitua, I., Tabuenca, J.M. and Vioque, A. (1987) Toxic oil syndrome case reports associated with the ITH oil refinery in Sevilla. Food Chem. Toxicol. 25, 87-90.
34. Posada, M., Philen, R.M., Abaitua, I., Diez, M., Abraira, V., Pozo, F., Pla, R., Pollán, M., Sicilia, J.M., Azpeitia, P., Woodruff, R. and Kilbourne, E.M. (1994) Factors associated with pathogenicity of oils related to the toxic oil syndrome epidemic in Spain. Epidemiology 5, 404-409.
35. Prigent, P., Poncet, P., Aten, J., Blandpied, C., Chand, A., Fébrier, M., Druet, P. and Hirsch, F. (1995) Mercuric chloride-induced programmed cell death of a murine T cell hybridoma. II. Opposite effect of interleukin-2 and interleukin-4. Cell. Immunol. 161, 107-111.
36. Rodrigo, J., Robles, M. and Mayo, I. (1983) Neurotoxicity of fatty acid anilides in rabbits. Lancet 1, 414-416.
37. Ruiz-Gutierrez, V. and Maestro-Duran, R. (1992) Lymphatic absorption of 3-phenylamino-1,2-propanediol and its esters. Exp. Toxicol. Pathol. 44, 29-33.
38. Sgonc, R. and Wick, R. (1994) Methods for the detection of apoptosis. Int. Arch. Allergy Immunol. 105, 327-332.
39. Sidransky, H., Verney, E., Cosgrove, J.W. and Latham, P.S. (1994) Effect of 3-phenylamino-L-alanine on tryptophan binding to rat hepatic nuclear envelopes. Toxicology 86, 135-145.
40. Smiley, J.D. (1992) The many faces of scleroderma. Am. J. Med. Sci. 304, 319-333.
41. Tabuenca, J.M. (1981) Toxic allergic syndrome caused by ingestion of rapeseed oil denatured with aniline. Lancet ii, 567-568.
42. Tan, E.M. (1994) Autoimmunity and apoptosis. J. Exp. Med. 179, 1083-1086.
43. Vazquez Roncero, A., Janer del Valle, C., Maestro Durán, R. and Graciani Constante, E. (1983) New aniline derivatives in cooking oils associated with the toxic oil syndrome. Lancet ii, 1024-1025.
44. Vazquez Roncero, A., Maestro Durán, R. and Ruiz Gutierrez, V. (1984) New aniline derivatives in toxic oil syndrome. Toxicity in mice of 3-phenylamino-1,2-propanediol and its fatty acid mono-and di-esters. Grasas y Aceites 35, 330-331.
45. WHO (1991) Toxic oil syndrome and eosinophilia-myalgia syndrome. Pursuing parallels in pathogenesis. Report on a WHO meeting, Washington, DC, WHO Regional Office for Europe, Copenhagen, pp. 22.
46. WHO (1992) Toxic oil syndrome: Current Knowledge and Future Perspectives. European Series, No. 42, WHO Regional Publications, Copenhagen.